DOI: 10.1055/s-00000069

Seminars in Liver Disease

Ausgabe 01 · Volume 36 · Februar 2016 DOI: 10.1055/s-006-30988 New Treatments in Liver Disease Guest Editors, Gregory J. Gores, MD, and Ariel E. Feldstein, MD

Editorial

  • 001
    Berk, Paul D.:

    A Farewell to Arms

  • 003
    Bruix, Jordi; Gores, Gregory J.:

    Inheriting a Jewel: A Thrilling Challenge

  • 005
    Williamson, Kate D.; Chapman, Roger W.:

    New Therapeutic Strategies for Primary Sclerosing Cholangitis

  • 015
    Corpechot, Christophe:

    Primary Biliary Cirrhosis Beyond Ursodeoxycholic Acid

  • 027
    Wree, Alexander; Mehal, Wajahat Z.; Feldstein, Ariel E.:

    Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis

  • 037
    Anand, Gobind; Zarrinpar, Amir; Loomba, Rohit:

    Targeting Dysbiosis for the Treatment of Liver Disease

  • 048
    Rahimi, Robert S.; Rockey, Don C.:

    Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia

  • 056
    Singal, Ashwani K.; Shah, Vijay H.:

    Therapeutic Strategies for the Treatment of Alcoholic Hepatitis

  • 069
    Fuchs, Claudia D.; Traussnigg, Stefan A.; Trauner, Michael:

    Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease

  • 087
    Yoon, Young Joon; Friedman, Scott L.; Lee, Youngmin A.:

    Antifibrotic Therapies: Where Are We Now?

    • Diagnostic Problems in Hepatology

  • 099
    Schneier, Amanda; Stueck, Ashley E.; Petersen, Bruce; Thung, Swan N.; Perumalswami, Ponni:

    An Unusual Cause of Acute Liver Failure: Three Cases of Hemophagocytic Lymphohistiocytosis Presenting at a Transplant Center